EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of Evolocumab on Grafts Post-Coronary Artery Bypass Surgery

G B John Mancini, Craig Kamimura, Michael Szarek, Eunice Yeoh, Arnold Ryomoto, Hwee Teoh, Adrian Quan, Randi Elituv, Meena Verma, Elizabeth Misner, Tarit Saha, Bobby Yanagawa und 7 weitere

JACC: Advances · 2026-09 · 5 (9) · 103162

DOI: 10.1016/j.jacadv.2026.103162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Advances, 2026-09. Verfasst von G B John Mancini und 18 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Imaging Core Laboratory, Centre for Cardiovascular Innovation, Dilawri Cardiovascular Institute, Division of Cardiology, Department of…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amgen Canada Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Graft failure remains a significant clinical problem. OBJECTIVES: This study aimed to evaluate effects of evolocumab on graft failure, stenosis severity, stenosis types, and plaque burden in saphenous vein grafts (SVGs), internal mammary artery (IMA), and radial artery grafts using coronary computed tomography angiography (CCTA). METHODS: Analysis of the randomized NEWTON-CABG CardioLink-5 trial was undertaken in evaluable grafts 24 months postsurgery. Graft stenosis was graded normal: 25% low-attenuation plaque (LAP), or spotty calcification. Plaque burden (calcified, mixed, or LAP) was measured. RESULTS: We studied 1,275 SVGs, 514 IMA grafts, and 39 radial artery grafts. There were no differences between treatment groups for graft failure in any graft type. Evolocumab had a lower percentage of moderate lesions among SVGs (11.5% vs 19.3%, P 25% LAP, or spotty calcification. SVGs accumulated more plaque burden but with greater percentage calcified (P < 0.002) and mixed plaque (P < 0.001) and less percentage LAP (P < 0.001) than IMA grafts. CONCLUSIONS: Evolocumab did not improve early graft failure, but exploratory results suggest that it may diminish moderate stenoses in SVGs and stenoses with unfavorable features. SVGs accumulated more plaque burden than IMA grafts but with less percentage LAP, possibly due to the early arterialization process involving smooth muscle cell proliferation, neointimal hyperplasia, and extracellular matrix expansion affecting only the SVGs.

Schlagwörter

Stichwörter der Autor:innen

evolocumabgraft failureinternal mammary artery graftlow attenuation plaqueradial artery graftsaphenous vein graft

Autor:innen und Institutionen

  • Cardiovascular Imaging Core Laboratory, Centre for Cardiovascular Innovation, Dilawri Cardiovascular Institute, Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia…
  • Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado, USA; CPC Clinical Research, University of Colorado School of Medicine, Aurora, Colorado, USA; Mount Sinai Fuster Heart Hospital, Icahn…
  • Division of Cardiac Surgery, St Michael's Hospital-Unity Health Toronto, Toronto, Ontario, Canada; Division of Endocrinology and Metabolism, St Michael's Hospital-Unity Health Toronto, Toronto, Ontario, Canada.
  • Division of Cardiac Surgery, St Michael's Hospital-Unity Health Toronto, Toronto, Ontario, Canada.
  • Division of Cardiac Surgery, St Michael's Hospital-Unity Health Toronto, Toronto, Ontario, Canada; North York Diagnostic and Cardiac Centre, Toronto, Ontario, Canada.
  • Royal College of Surgeons in Ireland, Dublin, Ireland.

Förderung

  • Amgen Canada Inc

Zitieren

APA

Mancini, G. B. J., Kamimura, C., Szarek, M., Yeoh, E., Ryomoto, A., Teoh, H., Quan, A., Elituv, R., Verma, M., Misner, E., Saha, T., Yanagawa, B., Jüni, P., Koren, M. J., Nicholls, S. J., Bhatt, D. L., Leiter, L. A., Mazer, C. D., & Verma, S. (2026). Effect of Evolocumab on Grafts Post-Coronary Artery Bypass Surgery. JACC: Advances, 5(9), 103162. https://doi.org/10.1016/j.jacadv.2026.103162

Vancouver

Mancini GBJ, Kamimura C, Szarek M, Yeoh E, Ryomoto A, Teoh H, et al. Effect of Evolocumab on Grafts Post-Coronary Artery Bypass Surgery. JACC: Advances. 2026;5(9):103162. doi:10.1016/j.jacadv.2026.103162

BibTeX
@article{Mancini2026,
  author = {Mancini, G B John and Kamimura, Craig and Szarek, Michael and Yeoh, Eunice and Ryomoto, Arnold and Teoh, Hwee and Quan, Adrian and Elituv, Randi and Verma, Meena and Misner, Elizabeth and Saha, Tarit and Yanagawa, Bobby and Jüni, Peter and Koren, Michael J and Nicholls, Stephen J and Bhatt, Deepak L and Leiter, Lawrence A and Mazer, C David and Verma, Subodh},
  title = {Effect of Evolocumab on Grafts Post-Coronary Artery Bypass Surgery},
  journal = {JACC: Advances},
  year = {2026},
  volume = {5},
  number = {9},
  pages = {103162},
  doi = {10.1016/j.jacadv.2026.103162}
}
Kostenlos starten →